Acute Coxiella burnetii infection presenting as sepsis with multisystem involvement in an immunosuppressed patient: a case report - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Severe Multisystem Sepsis Due to Acute Coxiella burnetii Infection in an Immunocompromised Individual: A Case Study

  • By

  • Yaozong Xia

  • Lin Fu

  • Xiu Cao

  • Xuxiang Zheng

  • Bin Nie

  • August 24, 2026

Share

Clinical Report: Severe Multisystem Sepsis Due to Acute Coxiella burnetii Infection

Background

Coxiella burnetii is the causative agent of Q fever, which can present as a severe disseminated illness, especially in immunocompromised individuals. Diagnosis is often complicated by the organism's intracellular nature and the limitations of conventional microbiological tests.

Data Highlights

Metagenomic next-generation sequencing identified C. burnetii nucleic acid sequences in the patient. Following doxycycline treatment, the patient's fever resolved and clinical parameters improved.

Key Findings

  • A 68-year-old man with rheumatoid arthritis developed severe multisystem sepsis.
  • Conventional microbiological tests, including blood cultures, were negative.
  • Metagenomic next-generation sequencing successfully identified C. burnetii.
  • Targeted treatment with doxycycline led to clinical improvement.

Clinical Implications

Healthcare providers should consider Q fever in immunocompromised patients presenting with severe infections of unknown origin. Metagenomic next-generation sequencing may serve as a valuable diagnostic tool in such cases.

Conclusion

This case demonstrates the potential of mNGS for timely pathogen detection.

Related Resources & Content

  1. CDC, Clinical Guidance for Q fever, 2025 -- Clinical Guidance for Q fever
  2. CDC, Clinical Case: Vascular Infection from Coxiella burnetii and Lymphoma in a Dutch Patient, 2017 -- Infection — Clinical Case: Vascular Infection from Coxiella burnetii and Lymphoma in a Dutch Patient
  3. Open Forum Infectious Diseases, Clinical Characteristics and Management Approaches for Q Fever-Related Spinal Infections, 2023 -- Clinical Characteristics and Management Approaches for Q Fever-Related Spinal Infections: A Comprehensive Review of 39 Cases and Relevant Literature
  4. Frontiers in Medicine — Severe cutaneous anthrax with systemic complications: a case report
  5. Frontiers in Medicine — Omadacycline for peritoneal dialysis-associated peritonitis caused by Coxiella burnetii: a case report and literature review
  6. Clinical and Laboratory Diagnosis for Q Fever | Q Fever | CDC
  7. Clinical Guidance for Q fever | Q Fever | CDC
  8. Treatment of persistent focalized Q fever: time has come for an international randomized controlled trial | Journal of Antimicrobial Chemotherapy | Oxford Academic

Original Source(s)

Related Content